AnteoTech Customer Ellume Secure US Contract
Filed with ASX · · 2 pages · English
Brisbane based nanotechnology company AnteoTech Ltd (ASX: ADO) (“AnteoTech” or “the Company”) notes our customer Ellume has made an announcement of an agreement with the U.S. Department of Defense (DOD) for its Emergency Use Authorization (EUA) COVID 19 at home test. As announced on 28 October 2016, Ellume integrates AnteoBind technology in their proprietary quantum dot diagnostics platform. The E
Earlier from AnteoTech
- Pause in Trading
- Appendix 4C - quarterly
- Up to $1.4m in Qld Grant for COVID-19 test development
- AnteoTech Progresses COVID-19 Test Toward Market Launch
- $3.9M Options Exercise Complete
Later from AnteoTech
- ASX App 4D and Interim Financial Report
- S&P DJI Announces March 2021 Quarterly Rebalance
- AnteoTech COVID-19 Antigen Rapid Test Clinical Study Result
- AnteoTech Joins $130M Future Battery Industries CRC
- Test Platform and COVID-19 Test receive CE Mark approval
Follow AnteoTech into a list and get an email when it puts out news.
Follow AnteoTech